-
N-MYC–eIF4G1 Axis in inv(16) AML
2026-09-11
This Science Advances study identifies an oncogenic N-MYC/eIF4G1 survival axis in inv(16) acute myeloid leukemia and defines a previously unrecognized MYCN enhancer that supports leukemic maintenance. Its integrated use of transcriptomic reanalysis, regulatory-element analysis, human leukemia models, and patient-derived xenografts provides a framework for connecting leukemia-specific transcriptional control to therapeutic vulnerability.
-
ARL4C Drives RA Fibroblast and Macrophage Dynamics
2026-09-11
The reference study integrates single-cell and bulk transcriptomics with ARL4C perturbation, FLS–macrophage co-culture, and collagen-induced arthritis experiments. Its findings position ARL4C as a regulator of aggressive fibroblast-like synoviocytes, macrophage polarization, PI3K/AKT and MAPK signaling, and joint damage, while identifying testable opportunities for orthogonal cell-cycle validation.
-
Pepstatin A for Aspartic Protease Workflows
2026-09-10
Pepstatin A enables selective interrogation of aspartic proteases across biochemical, viral protein processing, and osteoclast models. This practical guide connects inhibitor handling with assay design, controls, and the macrophage ACE2 findings of a recent SARS-CoV-2 study.
-
Ensemble-Based uPAR–uPA Inhibition and Cell Invasion
2026-09-10
The reference study introduced an ensemble-based virtual screening strategy to identify small-molecule inhibitors of the difficult uPAR·uPA protein–protein interaction. IPR-456 and related compounds demonstrated direct target engagement and reduced uPA binding and invasion in breast cancer cells, while the separation of invasion from migration and adhesion clarified the pathway’s biological specificity.
-
Sulforaphane Workflows for Redox and Inflammation
2026-09-09
Build reproducible Sulforaphane workflows that connect Keap1–Nrf2 signaling, cancer chemoprevention assays, and NLRP3-focused inflammation models. This guide translates mouse colitis findings into practical cell-culture, animal-study, assay-selection, and troubleshooting decisions.
-
Amorolfine Hydrochloride: Mapping Membrane Limits
2026-09-09
A translational perspective on using Amorolfine Hydrochloride to connect fungal membrane-synthesis perturbation with ploidy, cell-surface stress, and antifungal resistance studies. The article integrates budding-yeast evidence with practical assay design while distinguishing established findings from research hypotheses.
-
Pepstatin A as a Cathepsin D Probe in I/R Injury
2026-09-08
Pepstatin A is an aspartic protease inhibitor that can help distinguish cathepsin D-dependent effects from broader lysosomal changes in ischemia/reperfusion models. This article translates recent endothelial research into practical assay logic, dosing considerations, and cross-domain limitations.
-
Plant Virus Movement Protein Phase Separation
2026-09-07
Brown, Garrison, and May show that the Pea enation mosaic virus 2 movement protein p26 uses charge-dependent phase separation to associate with both proviral fibrillarin and antiviral G3BP compartments. Mutational, biochemical, and plant infection assays connect condensate partitioning with nucleolar trafficking, systemic movement, and restriction of viral RNA accumulation.
-
Cytosolic DNA and TDP-43 Homeostasis in Neurodegeneration
2026-09-07
A 2024 Journal of Biological Chemistry study identifies cytosolic DNA accumulation as a trigger of TDP-43 condensate formation, nuclear depletion, and short-isoform production. Its experiments connect DNA uptake, DNA damage, and impaired nuclear-envelope integrity with mechanisms relevant to TDP-43 proteinopathy in ALS and related neurodegenerative disease.
-
Sulforaphane, ROS, and NLRP3 in Experimental Colitis
2026-09-05
A 2024 study in Biomedicine & Pharmacotherapy links sulforaphane-mediated reduction of reactive oxygen species with suppression of NLRP3 inflammasome signaling in dextran sulfate sodium-induced mouse colitis. Its combined animal and RAW264.7 macrophage experiments provide a useful mechanistic framework for studying redox-sensitive inflammation while underscoring the limits of translating preclinical findings to human ulcerative colitis.
-
Rotigotine: Dopamine D2/D3 Agonist Workflows
2026-09-05
Rotigotine is a versatile dopamine D2/D3 receptor agonist for connecting receptor pharmacology with cellular neuroprotection and behavioral phenotyping. This workflow-focused guide translates antidepressant-model findings into practical Parkinson’s disease research, assay design, dosing, and troubleshooting decisions.
-
FPS-ZM1: A RAGE Inhibitor for Mechanistic Assays
2026-09-04
FPS-ZM1 enables receptor-focused studies of amyloid beta transport, cellular stress, and neuroinflammation while offering a practical way to test emerging RAGE/POMC biology. This workflow separates product-supported evidence from assay recommendations for Alzheimer’s disease research and metabolic neuroscience.
-
Mycobacterium tuberculosis WecA: Kinetic Study
2026-09-04
The reference study establishes a practical route for producing and functionally analyzing the difficult membrane enzyme WecA from Mycobacterium tuberculosis. Its controlled expression strategy, mass-spectrometric identity confirmation, UMP-based activity assay, and competitive inhibition analysis provide a useful platform for mechanistic research and WecA-directed anti-tuberculosis drug discovery.
-
Reelin Signaling Enables Ketamine Synaptic Action
2026-09-03
This PNAS study identifies Reelin–Apoer2–Src family kinase signaling as a permissive pathway for ketamine-induced hippocampal synaptic plasticity and behavioral effects. Its genetic, pharmacological, and electrophysiological evidence suggests that preserved baseline NMDA receptor function may help determine responsiveness to ketamine.
-
Leucomycin: Component-Aware Assay Design
2026-09-02
Leucomycin (kitasamycin) is best interpreted as a biologically active macrolide complex rather than a single uniform molecule. This guide explains how component composition, ribosomal mechanism, solvent handling, and resistance genetics should shape translational inhibition studies and bacterial growth inhibition assays.